BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24793368)

  • 1. Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder.
    Tuithof M; ten Have M; van den Brink W; Vollebergh W; de Graaf R
    Drug Alcohol Depend; 2014 Jul; 140():85-91. PubMed ID: 24793368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study.
    Tuithof M; Ten Have M; van den Brink W; Vollebergh W; de Graaf R
    Addiction; 2013 Dec; 108(12):2091-9. PubMed ID: 23889861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up.
    Dawson DA; Goldstein RB; Grant BF
    Alcohol Clin Exp Res; 2007 Dec; 31(12):2036-45. PubMed ID: 18034696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5.
    Tuithof M; Ten Have M; van den Brink W; Vollebergh W; de Graaf R
    Alcohol Clin Exp Res; 2014 Jan; 38(1):249-56. PubMed ID: 24033529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2.
    Tuithof M; ten Have M; van den Brink W; Vollebergh W; de Graaf R
    Drug Alcohol Depend; 2012 Jun; 123(1-3):115-21. PubMed ID: 22118715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the dimensionality of lifetime DSM-IV alcohol use disorders and a quantity-frequency alcohol use criterion in the Australian population: a factor mixture modelling approach.
    McBride O; Teesson M; Baillie A; Slade T
    Alcohol Alcohol; 2011; 46(3):333-41. PubMed ID: 21310744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol use in hazardous situations: implications for DSM-IV and DSM-5 alcohol use disorders.
    Mewton L; Slade T; Memedovic S; Teesson M
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E228-36. PubMed ID: 23078413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model.
    de Bruijn C; van den Brink W; de Graaf R; Vollebergh WA
    Addiction; 2006 Mar; 101(3):385-92. PubMed ID: 16499511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol Use Patterns and DSM-5 Alcohol Use Disorder on Both Sides of the U.S.-Mexico Border.
    Greenfield TK; Ye Y; Lown EA; Cherpitel CJ; Zemore S; Borges G
    Alcohol Clin Exp Res; 2017 Apr; 41(4):769-778. PubMed ID: 28207949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).
    Hardeveld F; Spijker J; De Graaf R; Nolen WA; Beekman AT
    Psychol Med; 2013 Jan; 43(1):39-48. PubMed ID: 23111147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Correlates of Past-Year Recovery From DSM-5 Alcohol Use Disorder: Results From National Epidemiologic Survey on Alcohol and Related Conditions-III.
    Fan AZ; Chou SP; Zhang H; Jung J; Grant BF
    Alcohol Clin Exp Res; 2019 Nov; 43(11):2406-2420. PubMed ID: 31580502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol abuse and dependence criteria as predictors of a chronic course of alcohol use disorders in the general population.
    de Bruijn C; van den Brink W; de Graaf R; Vollebergh WA
    Alcohol Alcohol; 2005; 40(5):441-6. PubMed ID: 16009673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers.
    Rubinsky AD; Dawson DA; Williams EC; Kivlahan DR; Bradley KA
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1380-90. PubMed ID: 23906469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent use of alcohol with other drugs and DSM-5 alcohol use disorder comorbid with other drug use disorders: Sociodemographic characteristics, severity, and psychopathology.
    Saha TD; Grant BF; Chou SP; Kerridge BT; Pickering RP; Ruan WJ
    Drug Alcohol Depend; 2018 Jun; 187():261-269. PubMed ID: 29689486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two single-item screeners for hazardous drinking and alcohol use disorder.
    Dawson DA; Pulay AJ; Grant BF
    Alcohol Clin Exp Res; 2010 Feb; 34(2):364-74. PubMed ID: 19951291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should symptom frequency be factored into scalar measures of alcohol use disorder severity?
    Dawson DA; Grant BF
    Addiction; 2010 Sep; 105(9):1568-79. PubMed ID: 20569231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of the 2-year recurrence and persistence of alcohol dependence.
    Boschloo L; Vogelzangs N; van den Brink W; Smit JH; Beekman AT; Penninx BW
    Addiction; 2012 Sep; 107(9):1639-40. PubMed ID: 22372473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSM-5 Alcohol Use Disorder Severity in Puerto Rico: Prevalence, Criteria Profile, and Correlates.
    Caetano R; Gruenewald P; Vaeth PAC; Canino G
    Alcohol Clin Exp Res; 2018 Feb; 42(2):378-386. PubMed ID: 29293264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of developmentally early alcohol use disorder symptom reports: a prospective-longitudinal community study.
    Behrendt S; Bühringer G; Perkonigg A; Lieb R; Beesdo-Baum K
    Drug Alcohol Depend; 2013 Aug; 131(3):308-15. PubMed ID: 23333293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 pandemic stressors are associated with reported increases in frequency of drunkenness among individuals with a history of alcohol use disorder.
    Meyers JL; McCutcheon VV; Horne-Osipenko KA; Waters LR; Barr P; Chan G; Chorlian DB; Johnson EC; Kuo SI; Kramer JR; Dick DM; Kuperman S; Kamarajan C; Pandey G; Singman D; de Viteri SS; Salvatore JE; Bierut LJ; Foroud T; Goate A; Hesselbrock V; Nurnberger J; Plaweck MH; Schuckit MA; Agrawal A; Edenberg HJ; Bucholz KK; Porjesz B
    Transl Psychiatry; 2023 Oct; 13(1):311. PubMed ID: 37803048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.